Diabetic Macular Ischemia Study

Now Open in Cincinnati, OH

Now Enrolling

When blood sugar is too high, the blood vessels in the retina of the eye can become blocked, causing inadequate blood flow. Diabetics are at risk of developing diabetic macular ischemia (DMI), a serious eye condition which can cause vision problems and even blindness. There is currently no medication approved to treat DMI. People age 18 or older may be eligible to join this research study of an investigational medication for DMI.

Eligible participants…

  • Must be age 18 or older
  • Must have received laser treatment for diabetic retinopathy
  • Must have an HbA1c level of ≤12%
  • May receive reimbursement for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.

Expect Excellence icon - supporting research since 1999

Submit your information

Study Location

Meridian Clinical Research
2055 Reading Rd., Suite 330
Cincinnati, OH 45202

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.